Early Death After Chemotherapy as a Quality Indicator-Is It Time to Bench the Benchmark?

Dunn, Catherine; Gately, Lucy; Gibbs, Peter

Dunn, Catherine; Gately, Lucy; Gibbs, Peter.

Afiliación

Dunn C; Personalised Medicine Division, Walter and Eliza Hall Research Institute, Melbourne, Victoria, Australia.
Gately L; Personalised Medicine Division, Walter and Eliza Hall Research Institute, Melbourne, Victoria, Australia.
Gibbs P; Personalised Medicine Division, Walter and Eliza Hall Research Institute, Melbourne, Victoria, Australia.

JAMA Oncol ; 8(11): 1559-1560, 2022 11 01.

Article en En | MEDLINE | ID: mdl-35980644

This Viewpoint examines chemotherapy at the end of life as a quality metric.

Asunto(s)

Benchmarking; Indicadores de Calidad de la Atención de Salud; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Benchmarking / Indicadores de Calidad de la Atención de Salud Límite: Humans Idioma: En Revista: JAMA Oncol Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google